| Pharmaceutical active ingredients: |
| Rotigotine |
| Available forms, composition and doses of Neupro: |
| Patch, Transdermal; Topical; Rotigotine 2 mg / 24 hPatch, Transdermal; Topical; Rotigotine 4 mg / 24 hPatch, Transdermal; Topical; Rotigotine 6 mg / 24 hPatch, Transdermal; Topical; Rotigotine 8 mg / 24 h |
| Neupro medical category: |
| Human:Non-ergoline dopamine agonistsParkinson's disease treatment drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N04BC09 - Rotigotine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Schwarz PharmaUCB PharmaZuellig Pharma |
| Related documents and information about Neupro: |
| Neupro prescribing information (PDF) |